Real-time enrollment status for this neuroendocrine tumors clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 10:16 AM UTC
| NCT Number | NCT06784752 |
| Recruiting Status | Recruiting |
| Condition | Neuroendocrine Tumors |
| Phase | Clinical Trial |
| Target Enrollment | 240 participants |
| Active Locations | 7 sites in the US |
| Sponsor | Novartis Pharmaceuticals |
| Last Updated on CT.gov | February 3, 2026 (3 weeks ago) |
As of March 2, 2026: Clinical trial NCT06784752 is currently recruiting participants. This clinical trial study for neuroendocrine tumors is actively seeking new participants at 7 locations across the United States. The study is sponsored by Novartis Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06784752 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 7 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06784752 was last updated 3 weeks ago (February 3, 2026). HelloStudys verifies this status automatically.